Cargando…
Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection
Chagas disease is an endemic chronic parasitosis in Latin America affecting more than 7 million people. Around 100 million people are currently at risk of acquiring the infection; however, no effective vaccine has been developed yet. Trypanosoma cruzi is the etiological agent of this parasitosis and...
Autores principales: | Antonoglou, María Belén, Sánchez Alberti, Andrés, Redolfi, Daniela María, Bivona, Augusto Ernesto, Fernández Lynch, María Julieta, Noli Truant, Sofía, Sarratea, María Belén, Iannantuono López, Laura Valeria, Malchiodi, Emilio Luis, Fernández, Marisa Mariel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338481/ https://www.ncbi.nlm.nih.gov/pubmed/32695105 http://dx.doi.org/10.3389/fimmu.2020.01279 |
Ejemplares similares
-
Superantigens, a Paradox of the Immune Response
por: Noli Truant, Sofia, et al.
Publicado: (2022) -
egc Superantigens Impair Monocytes/Macrophages Inducing Cell Death and Inefficient Activation
por: Noli Truant, Sofia, et al.
Publicado: (2020) -
Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi
por: Cerny, Natacha, et al.
Publicado: (2020) -
Cruzipain Promotes Trypanosoma cruzi Adhesion to Rhodnius prolixus Midgut
por: Uehara, Lívia Almeida, et al.
Publicado: (2012) -
Repertoire, Genealogy and Genomic Organization of Cruzipain and Homologous Genes in Trypanosoma cruzi, T. cruzi-Like and Other Trypanosome Species
por: Lima, Luciana, et al.
Publicado: (2012)